세포 표면 마커 시장 : 예측(2025-2030년)

The cell surface markers market is projected to grow at a CAGR of 8.05% over the forecast period, increasing from US$46.263 billion in 2025 to US$68.147 billion by 2030.

Cell surface markers are specialized proteins located on the surface of cells, serving as identifiers for specific cell types. They are crucial in determining the lineage of T cells and B cells and are expressed at particular times during a cell's lifecycle, allowing for the monitoring of growth and differentiation. Beyond identification, these markers play a significant role in drug discovery for personalized medicine, enabling researchers to target individual cells and develop new therapeutic options.

Drivers of the Cell Surface Markers Market:

• Innovative Technologies: Advances in technology are driving demand for applications involving cell surface markers. For example, researchers at the University of Illinois Urbana-Champaign have developed a tiny, four-fingered nanorobot made from a single piece of DNA that can identify the COVID-19 virus for rapid detection and block viral particles from infecting cells. This "NanoGripper" utilizes cell surface markers to interact with viruses, facilitating targeted drug delivery, such as in cancer treatment.

Geographical Trends Shaping the Cell Surface Markers Market:

• Asia-Pacific Expected to Experience Significant Growth: The global cell surface markers market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific. The Asia-Pacific region is anticipated to witness notable growth driven by increased production in the pharmaceutical and food & beverage sectors. Countries like China, Japan, India, and South Korea are leading producers of pharmaceutical products that use high-purity oleic acid as emulsifiers and excipients. The rising demand for food and beverages in this region will also contribute to market growth; oleic acid is frequently used in manufacturing synthetic butter and cheese as well as flavoring products like baked goods, ice cream, and sweets.

In summary, the cell surface markers market is poised for robust growth driven by technological advancements enhancing targeting capabilities, increasing consumer engagement with digital audio platforms, significant geographical developments-especially within Asia-Pacific-and rising demand for effective marketing solutions that leverage audio content.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The cell surface markers market has been segmented as following:

By Product

• Antibody
• PCR Array

By Cell Type

• T Cell
• B Cell
• NK Cell
• Monocyte Cell
• Others

By Source

• Human
• Mouse
• Rat
• Others

By Application

• Research
• Clinical

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Rest of South America
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Middle East and Africa
• Saudi Arabia
• UAE
• Rest of the Middle East and Africa
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Rest of Asia-Pacific

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process
• 2.3. Data Validation

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Supplier
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CELL SURFACE MARKERS MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Antibody
• 5.3. PCR Array

6. CELL SURFACE MARKERS MARKET BY CELL TYPE

• 6.1. Introduction
• 6.2. T Cell
• 6.3. B Cell
• 6.4. NK Cell
• 6.5. Monocyte Cell
• 6.6. Others

7. CELL SURFACE MARKERS MARKET BY SOURCE

• 7.1. Introduction
• 7.2. Human
• 7.3. Mouse
• 7.4. Rat
• 7.5. Others

8. CELL SURFACE MARKERS MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Research
• 8.3. Clinical

9. CELL SURFACE MARKERS MARKET BY GEOGRAPHY

• 9.1. Global Overview
• 9.2. North America
  • 9.2.1. United States
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Rest of South America
• 9.4. Europe
  • 9.4.1. United Kingdom
  • 9.4.2. Germany
  • 9.4.3. France
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Rest of Europe
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. United Arab Emirates
  • 9.5.3. Rest of the Middle East and Africa
• 9.6. Asia-Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Taiwan
  • 9.6.6. Thailand
  • 9.6.7. Indonesia
  • 9.6.8. Rest of Asia-Pacific

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Emerging Players and Market Lucrativeness
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Abbott Laboratories
• 11.2. Beckman Coulter Inc. (Danaher Corporation)
• 11.3. Becton, Dickinson, and Company (BD)
• 11.4. Bio-Rad Laboratories Inc.
• 11.5. Immucor Inc.
• 11.6. Nihon Kohden Corporation
• 11.7. Thermo Fisher Scientific Inc.
• 11.8. Siemens Healthineers
• 11.9. Sysmex Corporation
• 11.10. QIAGEN NV
• 11.11. Agilent Technologies Inc.
• 11.12. R&D Systems, Inc.
• 11.13. Bio-Techne